Correction to: CEST MRI provides amide/amine surrogate biomarkers for treatment‑naïve glioma sub‑typing

Affiliations

• ¹ Box65, Lysholm Department of Neuroradiology, The National Hospital for Neurology & Neurosurgery, University College London Hospitals NHS Foundation Trust, 8‑11 Queen Square, London, WC1N 3BG, UK. lmancini@nhs.net.
• ² Department of Brain Repair and Rehabilitation, UCL Queen Square Institute of Neurology, London, UK. lmancini@nhs.net.
• ³ Olea Medical, La Ciotat, France.
• ⁴ Department of Neurosurgery, The National Hospital for Neurology & Neurosurgery, University College London Hospitals NHS Foundation Trust, London, UK.
• ⁵ Division of Neuropathology, UCL Queen Square Institute of Neurology, London, UK.
• ⁶ The National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, UK.
• ⁷ Box65, Lysholm Department of Neuroradiology, The National Hospital for Neurology & Neurosurgery, University College London Hospitals NHS Foundation Trust, 8‑11 Queen Square, London, WC1N 3BG, UK.
• ⁸ Department of Brain Repair and Rehabilitation, UCL Queen Square Institute of Neurology, London, UK.
• ⁹ University College Hospital, University College of London Hospitals NHS Foundation Trust, London, UK.
• ¹⁰ Siemens Healthineers, Erlangen, Germany.